nach oben

International Journal of Mental Health and Addiction

Erschienen in:

20.01.2022 | Original Article

Opioid Use Stigma: An Examination of Student Attitudes on Harm Reduction Strategies

verfasst von: Gemma Reynolds, Brittany L. Lindsay, Stephanie Knaak, Andrew C. H. Szeto

Erschienen in: International Journal of Mental Health and Addiction | Ausgabe 6/2022

Einloggen, um Zugang zu erhalten

Abstract

Understanding how the public views harm reduction strategies may help inform researchers on how to reduce related stigma and barriers to help-seeking. The current study explored whether stigma towards those who use opioids was affected by gender and type of harm reduction strategy used. Undergraduate students (N = 328) were randomly assigned to read one of six vignettes varying by gender and the type of harm reduction strategy: no harm reduction, opioid agonist therapy (OAT), or safe consumption sites (SCSs). Results demonstrated that participants were less stigmatizing towards the character who engaged in OAT compared to the character with no harm reduction. There was also a pattern demonstrating that SCSs may be perceived more negatively than OAT, although these differences only met conventional significance, not adjusted/corrected alphas. There were no significant effects for gender. Qualitative results revealed that participants held misconceptions about harm reduction. Implications and future directions are discussed.

The Opening Minds Provider Attitudes Towards Opioid Use Scale (OM-PATOS; Knaak & Stuart, 2021) was originally included in the survey as a potential covariate, but it was realized post-hoc that the measure was too similar in construct to the dependent measures (but measured before the experimental manipulation) and was not used in the study.

Aflakseir, A., Esini, M. R., Goodarzi, M., & Molazadeh, J. (2019). Individuals with mental illness and stigma reduction: A cross-sectional study in a group of college students. Iranian Journal of Psychiatry, 14(4), 297–301. https://doi.org/10.18502/ijps.v14i4.1980

Alexander, L., & Link, B. (2003). The impact of contact on stigmatizing attitudes toward people with mental illness. Journal of Mental Health, 12(3), 271–289. https://doi.org/10.1080/0963823031000118267CrossRef

Allen, M. (Ed.). (2017). The sage encyclopedia of communication research methods. SAGE Publications. https://doi.org/10.4135/9781483381411

Baker, L. S., Smith, W., Gulley, T., & Tomann, M. M. (2019). Community perceptions of comprehensive harm reduction programs and stigma towards people who inject drugs in Rural Virginia. Journal of Community Health, 45(2), 239–244. https://doi.org/10.1007/s10900-019-00732-8CrossRef

Barry, C. L., & McGinty, E. E. (2014). Stigma and public support for parity and government spending on mental health: A 2013 national opinion survey. Psychiatric Services, 65(10), 1265–1268. https://doi.org/10.1176/appi.ps.201300550CrossRefPubMed

Barry, C. L., McGinty, E. E., Pescosolido, B. A., & Goldman, H. H. (2014). Stigma, discrimination, treatment effectiveness, and policy: Public views about drug addiction and mental illness. Psychiatric Services, 65(10), 1269–1272. https://doi.org/10.1176/appi.ps.201400140CrossRefPubMed

Becker, T. E. (2005). Potential problems in the statistical control of variables in organizational research: A qualitative analysis with recommendations. Organizational Research Methods, 8(3), 274–289. https://doi.org/10.1177/1094428105278021CrossRef

Bojko, M. J., Mazhnaya, A., Marcus, R., Makarenko, I., Islam, Z., Filippovych, S., Dvoriak, S., & Altice, F. L. (2016). The future of opioid agonist therapies in Ukraine: A qualitative assessment of multilevel barriers and ways forward to promote retention in treatment. Journal of Substance Abuse Treatment, 66, 37–47. https://doi.org/10.1016/j.jsat.2016.03.003CrossRefPubMedPubMedCentral

Bowleg, L. (2012). The problem with the phrase women and minorities: Intersectionality—an important theoretical framework for public health. American Journal of Public Health, 102(7), 1267–1273. https://doi.org/10.2105/AJPH.2012.300750CrossRefPubMedPubMedCentral

Broady, T. R., Brener, L., Cama, E., Hopwood, M., & Treloar, C. (2020). Stigmatising attitudes towards people who inject drugs, and people living with blood borne viruses or sexually transmissible infections in a representative sample of the Australian population. PLoS ONE, 15(4), 1–13. https://doi.org/10.1371/journal.pone.0232218CrossRef

Brown, S. A. (2011). Standardized measures for substance use stigma. Drug and Alcohol Dependence, 116(1–3), 137–141. https://doi.org/10.1016/j.drugalcdep.2010.12.005CrossRefPubMed

Burstein, P. (2003). The impact of public opinion on public policy: A review and an agenda. Political Research Quarterly, 56(1), 29–40. https://doi.org/10.1177/106591290305600103CrossRef

Campbell, C. I., Weisner, C., LeResche, L., Ray, G. T., Saunders, K., Sullivan, M. D., Banta-Green, C. J., Merrill, J. O., Silverberg, M. J., Boudreau, D., Satre, D. D., & Von Korff, M. (2010). Age and gender trends in long-term opioid analgesic use for noncancer pain. American Journal of Public Health, 100(12), 2541–2547. https://doi.org/10.2105/AJPH.2009.180646CrossRefPubMedPubMedCentral

Centers for Disease Control and Prevention (CDC). (2013). Vital signs: Overdoses of prescription opioid pain relievers and other drugs among women-United States, 1999–2010. MMWR. Morbidity and Mortality Weekly Report, 62(26), 537–542.

Centre for Addiction and Mental Health (2016). Opioid agonist therapy. https://www.camh.ca/-/media/files/oat-info-for-clients.pdf

Cooper, R. J. (2013). “I can” t be an addict. I am.’ Over-the-counter medicine abuse: A qualitative study. BMJ Open, 3(6). https://doi.org/10.1136/bmjopen-2013-002913

Corrigan, P. W., Druss, B. G., & Perlick, D. A. (2014). The impact of mental illness stigma on seeking and participating in mental health care. Psychological Science in the Public Interest, 15(2), 37–70. https://doi.org/10.1177/1529100614531398CrossRefPubMed

Corrigan, P. W., Markowitz, F. E., Watson, A., Rowan, D., & Kubiak, M. A. (2003). An attribution model of public discrimination towards persons with mental illness. Journal of Health and Social Behavior, 44(2), 162–179. https://doi.org/10.2307/1519806CrossRefPubMed

Corrigan, P. W., & Rao, D. (2012). On the self-stigma of mental illness: Stages, disclosure, and strategies for change. The Canadian Journal of Psychiatry, 57(8), 464–469. https://doi.org/10.1177/070674371205700804CrossRefPubMed

Corrigan, P. W., & Shapiro, J. R. (2010). Measuring the impact of programs that challenge the public stigma of mental illness. Clinical Psychology Review, 30(8), 907–922. https://doi.org/10.1016/j.cpr.2010.06.004CrossRefPubMedPubMedCentral

Csiernik, R., Rowe, W., & Watkin, J. (2017). Prevention as controversy: Harm reduction. In R. Csiernik & W. S. Rowe (Eds.) Responding to the oppression of addiction: Canadian social work responses (3^rd ed., pp. 28–47). Canadian Scholars' Press.

Davis, S. M., Davidov, D., Kristjansson, A. L., Zullig, K., Baus, A., & Fisher, M. (2018). Qualitative case study of needle exchange programs in the Central Appalachian region of the United States. PloS One, 13(10). https://doi.org/10.1371/journal.pone.0205466

Dear, M. (1992). Understanding and overcoming the NIMBY syndrome. Journal of the American Planning Association, 58(3), 288–300. https://doi.org/10.1080/01944369208975808CrossRef

DeLuca, J. S., & Yanos, P. T. (2016). Managing the terror of a dangerous world: Political attitudes as predictors of mental health stigma. International Journal of Social Psychiatry, 62(1), 21–30. https://doi.org/10.1177/0020764015589131CrossRefPubMed

Earnshaw, V., Smith, L., & Copenhaver, M. (2013). Drug addiction stigma in the context of methadone maintenance therapy: An investigation into understudied sources of stigma. International Journal of Mental Health and Addiction, 11(1), 110–122. https://doi.org/10.1007/s11469-012-9402-5CrossRefPubMed

Esses, V. M., & Maio, G. R. (2002). Expanding the assessment of attitude components and structure: The benefits of open-ended measures. European Review of Social Psychology, 12(1), 71–101. https://doi.org/10.1080/14792772143000021CrossRef

Fatani, S., Bakke, D., D’Eon, M., & El-Aneed, A. (2021). Qualitative assessment of patients’ perspectives and needs from community pharmacists in substance use disorder management. Substance Abuse Treatment, Prevention, and Policy, 16(1), 1–12. https://doi.org/10.1186/s13011-021-00374-xCrossRef

Faul, F., Erdfelder, E., Buchner, A., & Lang, A. G. (2009). Statistical power analyses using G* Power 3.1: Tests for correlation and regression analyses. Behavior Research Methods, 41(4), 1149–1160. https://doi.org/10.3758/BRM.41.4.1149

Gidman, W., & Coomber, R. (2014). Contested space in the pharmacy: Public attitudes to pharmacy harm reduction services in the West of Scotland. Research in Social and Administrative Pharmacy, 10(3), 576–587. https://doi.org/10.1016/j.sapharm.2013.07.006CrossRefPubMed

Goodyear, K., & Chavanne, D. (2020). Sociodemographic characteristics and the stigmatization of prescription opioid addiction. Journal of Addiction Medicine, 14(2), 150–155. https://doi.org/10.1097/ADM.0000000000000552CrossRefPubMedPubMedCentral

Goodyear, K., Haass-Koffler, C. L., & Chavanne, D. (2018). Opioid use and stigma: The role of gender, language and precipitating events. Drug and Alcohol Dependence, 185, 339–346. https://doi.org/10.1016/j.drugalcdep.2017.12.037CrossRefPubMedPubMedCentral

Harm Reduction International. (n.d.). What is harm reduction? Retrieved November 23, 2020, from https://www.hri.global/what-is-harm-reduction

Health Canada. (2020a). Opioids and the opioid crisis- Get the facts. Government of Canada. Retrieved November 23, 2020, from https://www.canada.ca/en/health-canada/services/substance-use/problematic-prescription-drug-use/opioids/get-the-facts.html

Health Canada. (2020b). Supervised consumption sites and services: Explained. Government of Canada. Retrieved November 23, 2020, from https://www.canada.ca/en/health-canada/services/substance-use/supervised-consumption-sites/explained.html

Henderson, C., Evans-Lacko, S., & Thornicroft, G. (2013). Mental illness stigma, help seeking, and public health programs. American Journal of Public Health, 103(5), 777–780. https://doi.org/10.2105/AJPH.2012.301056CrossRefPubMedPubMedCentral

Holmes, E. P., Corrigan, P. W., Williams, P., Canar, J., & Kubiak, M. A. (1999). Changing attitudes about schizophrenia. Schizophrenia Bulletin, 25(3), 447–456. https://doi.org/10.1093/oxfordjournals.schbul.a033392CrossRefPubMed

Hughes, R. (1998). Considering the vignette technique and its application to a study of drug injecting and HIV risk and safer behaviour. Sociology of Health & Illness, 20(3), 381–400. https://doi.org/10.1111/1467-9566.00107CrossRef

IBM Corp. (2019). IBM SPSS Statistics for Windows , Version 26.0. Armonk, NY: IBM Corp. [Computer software].

Javadi, R., Lagana, K., Krowicki, T., Bennett, D., & Schindler, B. (2021). Attitudes toward harm reduction among substance use treatment professionals in Philadelphia. Journal of Substance Use, 1–6. https://doi.org/10.1080/14659891.2021.1961320

Kennedy-Hendricks, A., Barry, C. L., Gollust, S. E., Ensminger, M. E., Chisolm, M. S., & McGinty, E. E. (2017). Social stigma toward persons with prescription opioid use disorder: Associations with public support for punitive and public health-oriented policies. Psychiatric Services, 68(5), 462–469. https://doi.org/10.1176/appi.ps.201600056CrossRefPubMed

Knaak, S., Beshara, J., Billett, M., Kharpal, K., & Patten, S. (2022). Measuring impacts of curricular content and personal story on substance use stigma. Journal of Nursing Education.

Knaak, S., Mantler, E., & Szeto, A. C. H. (2017). Mental illness-related stigma in healthcare: Barriers to access and care and evidence-based solutions. Healthcare Management Forum, 30, 111–116. https://doi.org/10.1177/0840470416679413CrossRefPubMedPubMedCentral

Knaak, S., Stuart, H. (2021). Measuring opioid-related stigma. In K. S. Dobson and H. Stuart (Eds.), The stigma of mental illness. Oxford University Press.

Lembke, A., & Zhang, N. (2015). A qualitative study of treatment-seeking heroin users in contemporary China. Addiction Science and Clinical Practice, 10(1), 1–8. https://doi.org/10.1186/s13722-015-0044-3CrossRef

Link, B. G., Cullen, F. T., Frank, J., & Wozniak, J. F. (1987). The social rejection of former mental patients: Understanding why labels matter. American Journal of Sociology, 92(6), 1461–1500. https://doi.org/10.1086/228672CrossRef

Link, B. G., & Phelan, J. C. (2001). Conceptualizing stigma. Annual review of. Sociology, 27(1), 363–385. https://doi.org/10.1146/annurev.soc.27.1.363CrossRef

Livingston, J. D. (2013). Mental illness-related structural stigma: The downward spiral of systemic exclusion final report. Mental Health Commission of Canada. https://www.mentalhealthcommission.ca/sites/default/files/MHCC_OpeningMinds_MentalIllness-RelatedSructuralStigmaReport_ENG_0_0.pdf

Livingston, J. D. (2020) Structural stigma in health-care contexts for people with mental health and substance use issues: A literature review. Mental Health Commission of Canada. https://www.mentalhealthcommission.ca/sites/default/files/2020-07/structural_stigma_in_healthcare_eng.pdf

MacCoun, R. J. (1998). Toward a psychology of harm reduction. American Psychologist, 53(11), 1199–1208. https://doi.org/10.1037/0003-066X.53.11.1199CrossRefPubMed

Mannarini, S., & Boffo, M. (2015). Anxiety, bulimia, drug and alcohol addiction, depression, and schizophrenia: What do you think about their aetiology, dangerousness, social distance, and treatment? A latent class analysis approach. Social Psychiatry and Psychiatric Epidemiology, 50(1), 27–37. https://doi.org/10.1007/s00127-014-0925-xCrossRefPubMed

Martínez-Hidalgo, M. N., Lorenzo-Sánchez, E., García, J. J. L., & Regadera, J. J. (2018). Social contact as a strategy for self-stigma reduction in young adults and adolescents with mental health problems. Psychiatry Research, 260, 443–450. https://doi.org/10.1016/j.psychres.2017.12.017CrossRefPubMed

McGinty, E. E., & Barry, C. L. (2020). Stigma reduction to combat the addiction crisis — Developing an evidence base. New England Journal of Medicine, 382(14), 1291–1292. https://doi.org/10.1056/nejmp2000227CrossRefPubMed

McGinty, E. E., Barry, C. L., Stone, E. M., Niederdeppe, J., Kennedy-Hendricks, A., Linden, S., & Sherman, S. G. (2018). Public support for safe consumption sites and syringe services programs to combat the opioid epidemic. Preventive Medicine, 111, 73–77. https://doi.org/10.1016/j.ypmed.2018.02.026CrossRefPubMed

McLean, S. A., Paxton, S. J., Massey, R., Hay, P. J., Mond, J. M., & Rodgers, B. (2014). Stigmatizing attitudes and beliefs about bulimia nervosa: Gender, age, education and income variability in a community sample. International Journal of Eating Disorders, 47(4), 353–361. https://doi.org/10.1002/eat.22227CrossRefPubMed

Mushtaq, S., Mendes, V., Nikolaou, V., & Luty, J. (2015). Analysis of the possible components of stigmatised attitudes towards depression and heroin dependence. Journal of Substance Use, 20(6), 399–406. https://doi.org/10.3109/14659891.2014.934306CrossRef

National Institute on Drug Abuse (2020a). Prescription opioids DrugFacts. Retrieved November 16, 2020, from https://www.drugabuse.gov/publications/drugfacts/prescription-opioids

National Institute on Drug Abuse. (2020b). What are misconceptions about maintenance treatment? Retrieved November 16, 2020, from https://www.drugabuse.gov/publications/research-reports/medications-to-treat-opioid-addiction/what-are-misconceptions-about-maintenance-treatment

OECD. (2019). Addressing problematic opioid use in OECD countries. OECD Publishing. https://doi.org/10.1787/a18286f0-enCrossRef

Penn, D. L., Guynan, K., Daily, T., Spaulding, W. D., Garbin, C. P., & Sullivan, M. (1994). Dispelling the stigma of schizophrenia: What sort of information is best? Schizophrenia Bulletin, 20(3), 567–578. https://doi.org/10.1093/schbul/20.3.567CrossRefPubMed

Rhodes, T., Watts, L., Davies, S., Martin, A., Smith, J., Clark, D., Craine, N., & Lyons, M. (2007). Risk, shame and the public injector: A qualitative study of drug injecting in South Wales. Social Science and Medicine, 65(3), 572–585. https://doi.org/10.1016/j.socscimed.2007.03.033CrossRefPubMed

Richard, E. L., Schalkoff, C. A., Piscalko, H. M., Brook, D. L., Sibley, A. L., Lancaster, K. E., Miller, W. C., & Go, V. F. (2020). “You are not clean until you’re not on anything”: Perceptions of medication-assisted treatment in rural Appalachia. International Journal of Drug Policy, 85, 102704. https://doi.org/10.1016/j.drugpo.2020.102704CrossRefPubMed

Rosenberg, H., & Phillips, K. T. (2003). Acceptability and availability of harm-reduction interventions for drug abuse in American substance abuse treatment agencies. Psychology of Addictive Behaviors, 17(3), 203. https://doi.org/10.1037/0893-164X.17.3.203CrossRefPubMed

Sattler, S., Escande, A., Racine, E., & Göritz, A. S. (2017). Public stigma toward people with drug addiction: A factorial survey. Journal of Studies on Alcohol and Drugs, 78(3), 415–425. https://doi.org/10.15288/jsad.2017.78.415

Simmonds, L., & Coomber, R. (2009). Injecting drug users: A stigmatised and stigmatising population. International Journal of Drug Policy, 20(2), 121–130. https://doi.org/10.1016/j.drugpo.2007.09.002CrossRefPubMed

Special Advisory Committee on the Epidemic of Opioid Overdoses (2021, June). Opioid and stimulant-related harms in Canada. Public Health Agency of Canada. Retrieved August 15, 2021, from https://health-infobase.canada.ca/substance-related-harms/opioids-stimulants

Stuart, H. (2019). Managing the stigma of opioid use. Healthcare Management Forum, 32(2), 78–83. https://doi.org/10.1177/0840470418798658CrossRefPubMed

Terplan, M. (2017). Women and the opioid crisis: Historical context and public health solutions. Fertility and Sterility, 108(2), 195–199. https://doi.org/10.1016/j.fertnstert.2017.06.007CrossRefPubMed

Tostes, J. G. D. A., Dias, R. T., Reis, A. A. D. S., Silveira, P. S. D., & Ronzani, T. M. (2020). Intervenções para redução do estigma relacionado às pessoas que usam drogas: Revisão sistemática [Interventions to reduce stigma related to people who use drugs: Systematic review]. Paidéia (ribeirão Preto), 30, e3022. https://doi.org/10.1590/1982-4327e3022CrossRef

Turan, J. M., Elafros, M. A., Logie, C. H., Banik, S., Turan, B., Crockett, K. B., Pescosolido, B., & Murray, S. M. (2019). Challenges and opportunities in examining and addressing intersectional stigma and health. BMC Medicine, 17(1), 1–15. https://doi.org/10.1186/s12916-018-1246-9CrossRef

VanHouten, J. P., Rudd, R. A., Ballesteros, M. F., & Mack, K. A. (2019). Drug overdose deaths among women aged 30–64 years—United States, 1999–2017. Morbidity and Mortality Weekly Report, 68(1), 1–5. https://doi.org/10.15585/mmwr.mm6801a1

Watson, T. M., Bayoumi, A., Kolla, G., Penn, R., Fischer, B., Luce, J., & Strike, C. (2012). Police perceptions of supervised consumption sites (SCSs): A qualitative study. Substance Use and Misuse, 47(4), 364–374. https://doi.org/10.3109/10826084.2011.645104CrossRefPubMed

Weeks, C., & Stenstrom, D. M. (2020). Stigmatization of opioid addiction based on prescription, sex and age. Addictive Behaviors, 108, 106469. https://doi.org/10.1016/j.addbeh.2020.106469CrossRefPubMed

Wirth, J. H., & Bodenhausen, G. V. (2009). The role of gender in mental-illness stigma: A national experiment. Psychological Science, 20(2), 169–173. https://doi.org/10.1111/j.1467-9280.2009.02282.xCrossRefPubMed

Woo, J., Bhalerao, A., Bawor, M., Bhatt, M., Dennis, B., Mouravska, N., Zielinkski, L., & Samaan, Z. (2017). “Don’t judge a book by its cover”: A qualitative study of methadone patients’ experiences of stigma. Substance Abuse: Research and Treatment, 11, 11–12. https://doi.org/10.1177/1178221816685087CrossRef

Titel: Opioid Use Stigma: An Examination of Student Attitudes on Harm Reduction Strategies
verfasst von: Gemma Reynolds
Brittany L. Lindsay
Stephanie Knaak
Andrew C. H. Szeto
Publikationsdatum: 20.01.2022
Verlag: Springer US
Erschienen in: International Journal of Mental Health and Addiction / Ausgabe 6/2022
Print ISSN: 1557-1874
Elektronische ISSN: 1557-1882
DOI: https://doi.org/10.1007/s11469-022-00756-7

Neu im Fachgebiet Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

23.04.2024 Depression antepartal oder postpartal Nachrichten

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2022

Individuals to Systems: Methodological and Conceptual Considerations for Addressing Mental Illness Stigma Holistically

Implementing and Sustaining Brief Addiction Medicine Interventions with the Support of a Quality Improvement Blended-eLearning Course: Learner Experiences and Meaningful Outcomes in Kenya

Adolescents’ Continuum and Categorical Beliefs, Help-seeking Intentions, and Stigma Towards People Experiencing Depression or Schizophrenia

The Relationship Between Sexual and Gender Stigma and Difficulty Accessing Primary and Mental Healthcare Services Among LGBTQI + Populations in Thailand: Findings from a National Survey

Interdisciplinary and International Perspectives on Mental Illness and Substance Use Stigma

The Relationship Between Sexual Behavior Stigma and Depression Among Men Who have Sex with Men and Transgender Women in Kigali, Rwanda: a Cross-sectional Study